Ke Hu
- Hepatology top 1%
- Hepatitis C virus research 10
- Biomaterials top 2%
- Molecular Medicine top 2%
- Biomedical Engineering top 5%
- 3D Printing in Biomedical Research 17
- Nanoplatforms for cancer theranostics 11
- Graphene and Nanomaterials Applications 9
- Bone Tissue Engineering Materials 8
- Molecular Biology top 10%
-
- Tissue Engineering and Regenerative Medicine 8
-
- Multiple Myeloma Research and Treatments 8
-
- Liver Disease Diagnosis and Treatment 7
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ke Hu
167 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 171
- Hepatology 539
- Biomaterials 693
- Molecular Medicine 179
- Biomedical Engineering 915
- Molecular Biology 1.1k
Countries citing papers authored by Ke Hu
This map shows the geographic impact of Ke Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Hu more than expected).
Fields of papers citing papers by Ke Hu
This network shows the impact of papers produced by Ke Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Hu. The network helps show where Ke Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 6 | |
| 4 | 2025 | 7 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 9 | |
| 14 | 2022 | 18 | |
| 15 | 2022 | 23 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 23 | |
| 18 | 2021 | 15 | |
| 19 | 2017 | 26 | |
| 20 | Inhibited effect of Chlorogenic acid on virus in vitro | 2001 | 4 |
About Ke Hu
Ke Hu is a scholar working on Hepatology, Transplantation and Biomaterials, having authored 177 papers that have together received 3.7k indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (17 papers), Nanoplatforms for cancer theranostics (11 papers), Hepatitis C virus research (10 papers), Graphene and Nanomaterials Applications (9 papers), Tissue Engineering and Regenerative Medicine (8 papers), Multiple Myeloma Research and Treatments (8 papers), Bone Tissue Engineering Materials (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (539 citations), Biomaterials (693 citations) and Molecular Medicine (179 citations). Ke Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ning Gu, Xin‐Sheng Yao, Jianfei Sun, Jane A. McKeating, Peter Balfe, Zhaobin Guo, Ming Ma, Yiyun Cheng, Helen J. Harris and Zania Stamataki. Their work appears in journals such as Advanced Materials, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.